152 related articles for article (PubMed ID: 36275480)
1. An Acid Response IR780-Based Targeted Nanoparticle for Intraoperative Near-Infrared Fluorescence Imaging of Ovarian Cancer.
Song J; Ye H; Jiang S; Yang Y; Li X
Int J Nanomedicine; 2022; 17():4961-4974. PubMed ID: 36275480
[TBL] [Abstract][Full Text] [Related]
2. IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer.
Song J; Zhang N; Zhang L; Yi H; Liu Y; Li Y; Li X; Wu M; Hao L; Yang Z; Wang Z
Int J Nanomedicine; 2019; 14():2757-2772. PubMed ID: 31118609
[No Abstract] [Full Text] [Related]
3. Folate-targeted Pluronic-chitosan nanocapsules loaded with IR780 for near-infrared fluorescence imaging and photothermal-photodynamic therapy of ovarian cancer.
Potara M; Nagy-Simon T; Focsan M; Licarete E; Soritau O; Vulpoi A; Astilean S
Colloids Surf B Biointerfaces; 2021 Jul; 203():111755. PubMed ID: 33862575
[TBL] [Abstract][Full Text] [Related]
4. Tumor-activated targetable photothermal chemotherapy using IR780/zoledronic acid-containing hybrid polymeric nanoassemblies with folate modification to treat aggressive breast cancer.
Liu YL; Wang TH; Yeh NT; Huang WJ; Tzang BS; Wu IT; Chin HY; Hu SH; Hsu TC; Chiang WH
Nanoscale; 2024 Jan; 16(3):1415-1427. PubMed ID: 38167914
[TBL] [Abstract][Full Text] [Related]
5. Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles.
Li S; Johnson J; Peck A; Xie Q
J Transl Med; 2017 Jan; 15(1):18. PubMed ID: 28114956
[TBL] [Abstract][Full Text] [Related]
6. Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy.
Liang X; Fang L; Li X; Zhang X; Wang F
Biomaterials; 2017 Jul; 132():72-84. PubMed ID: 28411450
[TBL] [Abstract][Full Text] [Related]
7. FA-NBs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer.
Shen Y; Lv W; Yang H; Cai W; Zhao P; Zhang L; Zhang J; Yuan L; Duan Y
Cancer Lett; 2019 Jul; 455():14-25. PubMed ID: 31018151
[TBL] [Abstract][Full Text] [Related]
8. NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models.
Pu T; Liu Y; Pei Y; Peng J; Wang Z; Du M; Liu Q; Zhong F; Zhang M; Li F; Xu C; Zhang X
ACS Appl Mater Interfaces; 2023 Jul; 15(27):32226-32239. PubMed ID: 37385963
[TBL] [Abstract][Full Text] [Related]
9. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.
Samykutty A; Grizzle WE; Fouts BL; McNally MW; Chuong P; Thomas A; Chiba A; Otali D; Woloszynska A; Said N; Frederick PJ; Jasinski J; Liu J; McNally LR
Biomaterials; 2018 Nov; 182():114-126. PubMed ID: 30118979
[TBL] [Abstract][Full Text] [Related]
10. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
11. IR780-dye loaded gold nanoparticles as new near infrared activatable nanotheranostic agents for simultaneous photodynamic and photothermal therapy and intracellular tracking by surface enhanced resonant Raman scattering imaging.
Nagy-Simon T; Potara M; Craciun AM; Licarete E; Astilean S
J Colloid Interface Sci; 2018 May; 517():239-250. PubMed ID: 29428811
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte Membrane-Camouflaged IR780 and DTX Coloading Polymeric Nanoparticles for Imaging-Guided Cancer Photo-Chemo Combination Therapy.
Yang Q; Xiao Y; Yin Y; Li G; Peng J
Mol Pharm; 2019 Jul; 16(7):3208-3220. PubMed ID: 31145853
[TBL] [Abstract][Full Text] [Related]
13. Exceptionally High Payload of the IR780 Iodide on Folic Acid-Functionalized Graphene Quantum Dots for Targeted Photothermal Therapy.
Li S; Zhou S; Li Y; Li X; Zhu J; Fan L; Yang S
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22332-22341. PubMed ID: 28643511
[TBL] [Abstract][Full Text] [Related]
14. IR780-based diffuse fluorescence tomography for cancer detection.
He Z; Zhang L; Xing L; Sun W; Gao X; Zhang Y; Gao F
J Biophotonics; 2024 May; 17(5):e202300493. PubMed ID: 38329194
[TBL] [Abstract][Full Text] [Related]
15. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
Guo F; Yu M; Wang J; Tan F; Li N
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
[TBL] [Abstract][Full Text] [Related]
16. A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.
Hoogstins CE; Tummers QR; Gaarenstroom KN; de Kroon CD; Trimbos JB; Bosse T; Smit VT; Vuyk J; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
Clin Cancer Res; 2016 Jun; 22(12):2929-38. PubMed ID: 27306792
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
Lian H; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.
Chen J; Zhang C; Guo Y; Chang X; Ma R; Ye X; Cheng H; Li Y; Cui H
World J Surg Oncol; 2020 Apr; 18(1):66. PubMed ID: 32252772
[TBL] [Abstract][Full Text] [Related]
19. NIR-responsive nanoplatform for pre/intraoperative image-guided carcinoma surgery and photothermal ablation of residual tumor tissue.
Song J; Zhang L; Yi H; Huang J; Zhang N; Zhong Y; Hao L; Ke Yang ; Wang Z; Wang D; Yang Z
Nanomedicine; 2019 Aug; 20():102020. PubMed ID: 31125675
[TBL] [Abstract][Full Text] [Related]
20. Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer.
Yang H; Zhao P; Zhou Y; Li Q; Cai W; Zhao Z; Shen J; Yao K; Duan Y
Sci Rep; 2021 Mar; 11(1):6254. PubMed ID: 33737559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
